1. Home
  2. News
  3. News by sector: clinical & Date: 2022/03

News : clinical, Mar 2022

View by sector:
Go

Hardy Diagnostics Now Offers the BioCode® MDx-3000

BioCode MDx 3000
AutomationGastro-Intestinal PanelRespiratory Panel
30 Mar 2022
Hardy Diagnostics announces it is the exclusive U.S. distribution partner of the automated, high throughput, multiplex molecular diagnostic system developed by Applied BioCode

Recombinant Antigens for 2022-2023 Influenza Vaccine Strains

Recombinant Flu Antigen Products
Assay DevelopmentInfluenza
24 Mar 2022
Sino Biological has recently launched recombinant HA, NA, and NP proteins for 2022-2023 influenza vaccine strains, adding to its comprehensive collection of influenza antigens from all WHO-recommended vaccine strains in recent years.

Sino Biological and Ainnocence Partner to Offer Next-Generation Antibody Development CRO Services

Sino and AInnocence
Artifical IntelligenceAssay Development
24 Mar 2022
Sino Biological will partner with Ainnocence and add the San Jose company's cutting-edge artificial intelligence-based prediction technology to its current antibody development CRO services offering.

Crucial Tools for COVID-19 Omicron Research

Omicron pseudotyped lentiviruses and spike neutralizing antibodies
Assay DevelopmentSARS-CoV-2
22 Mar 2022
New to the AMSBIO range are recombinant proteins, easy-to-perform assay kits, Omicron pseudotyped lentiviruses and spike neutralizing antibodies for use in functional assays to block SARS-CoV-2 spike protein and ACE2 binding.

Bulk Gold Nanomaterials for Point of Care Diagnostics

gold colloid and gold Nanoshells
Lateral Flow Assays
22 Mar 2022
Solutions to meet your performance, quality, cost, and scale requirements

CE Marking for Veros™ COVID-19 Rapid, Instrument-Free Molecular Test

Image not available
Point of Care/NeedSARS-CoV-2
15 Mar 2022
CE Marked Veros COVID-19 delivers PCR quality testing in just minutes without the need for an instrument or reader, no external power supply required.

Sino Biological Invests Over 200M RMB to Establish New Subsidiaries in Taizhou and Suzhou, China.

Sino New Subsidiaries
14 Mar 2022
Sino Biological is pleased to announce the formation of two new operationally-focused subsidiaries in Taizhou and Suzhou further cementing its geographical footprint in China with the addition of the subsidiaries

New Non-Hazardous Viral Inactivation Medium Supports Safe Collection and Transport of SARS-CoV-2

Inactivation Medium for SARS-CoV-2
SARS-CoV-2Swabs with Transport Medium
11 Mar 2022
InhibiSURE Viral Inactivation Medium has a breakthrough formulation helping to reduce the risk of exposure using a non-hazardous formulation and leakproof format during transport and processing.

Hardy Diagnostics Strep B Carrot Broth™ Saving the Lives of Newborns

Strep B Carrot Broth
Streptococcus - Group B
07 Mar 2022
Strep B Carrol Broth™ One-Step is Hardy Diagnostics exclusive one-step system that allows for faster results for the cultivation and identification of beta-hemolytic strains of Group B Streptococcus in pregnant women.

Superior Microbiology Technology That Saves The Environment From Mega-Tons Of Petri Dish Waste 

Roth Bioscience RCard
E. coliEnterobacteriaceaeTotal Counts
04 Mar 2022
With the Roth Bioscience R-CARD®, there is no pre-preparation of media.  The R-CARD is 12 mils thick (flat), by 3.5 X 4.0 inches, so is space (shipping/storage) saving and disposal is a tiny fraction of the bulk of environmentally clogging Petri dishes.

FILTER BY SECTOR

Unmasking endotoxins webinar
advertisement
Hygiena Ensure Touch
advertisement
MRSA qPCR Detection kit
advertisement
Browse this rapidmicrobiology special focus on automation and ergonomics in the microbiology lab
advertisement

LATEST MICROBIOLOGY NEWS

MICROBIOLOGY EVENTS

RMB LOGO

Get all the latest updates on products and services for your microbiology lab in the free weekly rapidmicrobiology newsletter - sign up now!

Contact info

  • Rapid Test Methods Ltd
  • C/O Xeinadin,
    BLDG G West Cork Technology Park,
    Clonakilty, CORK,
    Ireland P85 VF62
  • +[353] 2388 31884
  • info@rapidmicrobiology.com

Submit

rapidmicrobiology

Other sections

© 2001 - 2025 Rapid Test Methods Ltd. All rights reserved.